Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 41 Records) |
Query Trace: Decision Making and BRCA2[original query] |
---|
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study. Breast cancer research : BCR 2012 14 (6): R156. Rhiem Kerstin, Engel Christoph, Graeser Monika, Zachariae Silke, Kast Karin, Kiechle Marion, Ditsch Nina, Janni Wolfgang, Mundhenke Christoph, Golatta Michael, Varga Dominic, Preisler-Adams Sabine, Heinrich Tilman, Bick Ulrich, Gadzicki Dorothea, Briest Susanne, Meindl Alfons, Schmutzler Rita |
Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Annals of surgical oncology 2013 Oct 20 (10): 3254-8. Greenup Rachel, Buchanan Adam, Lorizio Wendy, Rhoads Keelia, Chan Salina, Leedom Tracey, King Robin, McLennan Jane, Crawford Beth, Kelly Marcom P, Shelley Hwang |
Dissimilarity between sporadic, non-BRCA1/2 families and hereditary breast cancer, linked to BRCA genes, in the Tunisian population. Breast cancer (Tokyo, Japan) 2015 Oct . Riahi Aouatef, Gourabi Mohamel El, Chabouni-Bouhamed Habi |
Hereditary breast and ovarian cancer: new genes in confined pathways. Nature reviews. Cancer 2016 Aug . Nielsen Finn Cilius, van Overeem Hansen Thomas, Sørensen Claus Storgaa |
Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes. Annals of surgical oncology 2017 8 24 (10): 3067-3072. Welsh Jessemae L, Hoskin Tanya L, Day Courtney N, Thomas Abigail S, Cogswell Jodie A, Couch Fergus J, Boughey Judy |
Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance. Annals of surgical oncology 2017 8 24 (10): 3048-3054. Gilbert Elizabeth, Zabor Emily C, Stempel Michelle, Mangino Debra, Heerdt Alexandra, Pilewskie Melis |
Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers. Journal of genetic counseling 2018 6 27 (6): 1386-1394. Mor Pnina, Brennenstuhl Sarah, Metcalfe Kelly |
Prevalence of pathogenic variants and variants of unknown significance in patients at high risk of breast cancer: A systematic review and meta-analysis of gene-panel data. Critical reviews in oncology/hematology 2018 11 132 138-144. van Marcke C, Collard A, Vikkula M, Duhoux F |
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction. Frontiers in oncology 2018 11 8 480. Caleca Laura, Catucci Irene, Figlioli Gisella, De Cecco Loris, Pesaran Tina, Ward Maggie, Volorio Sara, Falanga Anna, Marchetti Marina, Iascone Maria, Tondini Carlo, Zambelli Alberto, Azzollini Jacopo, Manoukian Siranoush, Radice Paolo, Peterlongo Pao |
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition. British journal of cancer 2018 01 118 (2): 266-276. Mikropoulos Christos, Selkirk Christina G Hutten, Saya Sibel, Bancroft Elizabeth, Vertosick Emily, Dadaev Tokhir, Brendler Charles, Page Elizabeth, Dias Alexander, Evans D Gareth, Rothwell Jeanette, Maehle Lovise, Axcrona Karol, Richardson Kate, Eccles Diana, Jensen Thomas, Osther Palle J, van Asperen Christi J, Vasen Hans, Kiemeney Lambertus A, Ringelberg Janneke, Cybulski Cezary, Wokolorczyk Dominika, Hart Rachel, Glover Wayne, Lam Jimmy, Taylor Louise, Salinas Monica, Feliubadaló Lidia, Oldenburg Rogier, Cremers Ruben, Verhaegh Gerald, van Zelst-Stams Wendy A, Oosterwijk Jan C, Cook Jackie, Rosario Derek J, Buys Saundra S, Conner Tom, Domchek Susan, Powers Jacquelyn, Ausems Margreet Gem, Teixeira Manuel R, Maia Sofia, Izatt Louise, Schmutzler Rita, Rhiem Kerstin, Foulkes William D, Boshari Talia, Davidson Rosemarie, Ruijs Marielle, Helderman-van den Enden Apollonia Tjm, Andrews Lesley, Walker Lisa, Snape Katie, Henderson Alex, Jobson Irene, Lindeman Geoffrey J, Liljegren Annelie, Harris Marion, Adank Muriel A, Kirk Judy, Taylor Amy, Susman Rachel, Chen-Shtoyerman Rakefet, Pachter Nicholas, Spigelman Allan, Side Lucy, Zgajnar Janez, Mora Josefina, Brewer Carole, Gadea Neus, Brady Angela F, Gallagher David, van Os Theo, Donaldson Alan, Stefansdottir Vigdis, Barwell Julian, James Paul A, Murphy Declan, Friedman Eitan, Nicolai Nicola, Greenhalgh Lynn, Obeid Elias, Murthy Vedang, Copakova Lucia, McGrath John, Teo Soo-Hwang, Strom Sara, Kast Karin, Leongamornlert Daniel A, Chamberlain Anthony, Pope Jenny, Newlin Anna C, Aaronson Neil, Ardern-Jones Audrey, Bangma Chris, Castro Elena, Dearnaley David, Eyfjord Jorunn, Falconer Alison, Foster Christopher S, Gronberg Henrik, Hamdy Freddie C, Johannsson Oskar, Khoo Vincent, Lubinski Jan, Grindedal Eli Marie, McKinley Joanne, Shackleton Kylie, Mitra Anita V, Moynihan Clare, Rennert Gad, Suri Mohnish, Tricker Karen, , Moss Sue, Kote-Jarai Zsofia, Vickers Andrew, Lilja Hans, Helfand Brian T, Eeles Rosalind |
Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma. BMC cancer 2019 4 19 (1): 296. Gornjec Andreja, Novakovic Srdjan, Stegel Vida, Hocevar Marko, Pohar Marinsek Ziva, Gazic Barbara, Krajc Mateja, Skof Er |
A Reference System for BRCA Mutation Detection Based on Next-Generation Sequencing in the Chinese Population. The Journal of molecular diagnostics : JMD 2019 4 21 (4): 677-686. Qu Shoufang, Chen Qiong, Yi Yuting, Shao Kang, Zhang Wenxin, Wang Yin, Bai Jian, Li Xuchao, Liu Zhiyuan, Wang Xiaowen, Jing Ruilin, Guan Yanfang, Yi Xin, Yan Miaoli, Cao Boyang, Chen Feng, Zhu Shida, Yang Xuexi, Wu Yingsong, Huang J |
Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation. Cancers 2019 Apr 11 (4): . Golubeva Volha A, Nepomuceno Thales C, Monteiro Alvaro N |
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genetics in medicine : official journal of the American College of Medical Genetics 2019 1 21 (8): 1708-1718. Lee Andrew, Mavaddat Nasim, Wilcox Amber N, Cunningham Alex P, Carver Tim, Hartley Simon, Babb de Villiers Chantal, Izquierdo Angel, Simard Jacques, Schmidt Marjanka K, Walter Fiona M, Chatterjee Nilanjan, Garcia-Closas Montserrat, Tischkowitz Marc, Pharoah Paul, Easton Douglas F, Antoniou Antonis |
Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco. BMC cancer 2020 Sep 20 (1): 859. Bakkach Joaira, Mansouri Mohamed, Derkaoui Touria, Loudiyi Ali, El Fahime ElMostafa, Barakat Amina, Ghailani Nourouti Naima, Martinez De Villarreal Jaime, Cortijo Bringas Carlos, Bennani Mechita Mohci |
Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study. Annals of surgical oncology 2020 9 28 (4): 2219-2226. Metcalfe Kelly A, Eisen Andrea, Poll Aletta, Candib Alexandra, McCready David, Cil Tulin, Wright Frances, Lerner-Ellis Jordan, McCuaig Jeanna, Graham Tracy, Sun Ping, Akbari Mohammad, Narod Steven |
Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. Cancer science 2020 Aug . Ryu Jin-Sun, Lee Hye-Young, Cho Eun Hae, Yoon Kyong-Ah, Kim Min-Kyeong, Joo Jungnam, Lee Eun-Sook, Kang Han-Sung, Lee Seeyoun, Lee Dong Ock, Lim Myong Cheol, Kong Sun-You |
Recurrent BRCA1 Mutation, but no BRCA2 Mutation, in Vietnamese Patients with Ovarian Carcinoma Detected with Next Generation Sequencing. Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21 (8): 2331-2335. Vu Hoang Anh, Phu Ngo Dai, Khuong Le Thai, Hoa Pham Huy, Nhu Bui Thi Hong, Nhan Vo Thanh, Thanh Le Quang, Sinh Nguyen Duy, Chi Hoang Thanh, Quan Nguyen Dang, Binh Nguyen Tro |
The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study. Radiology and oncology 2020 May 54 (2): 180-186. Gornjec Andreja, Merlo Sebastijan, Novakovic Srdjan, Stegel Vida, Gazic Barbara, Perhavec Andraz, Blatnik Ana, Krajc Mate |
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers. The journal of pathology. Clinical research 2020 Feb . McCrorie Alan D, Ashfield Susannah, Begley Aislinn, Mcilmunn Colin, Morrison Patrick J, Boyd Clinton, Eccles Bryony, Greville-Heygate Stephanie, Copson Ellen R, Cutress Ramsey I, Eccles Diana M, Savage Kienan I, McIntosh Stuart |
Influence of germline test results on surgical decision making in women with invasive breast cancer. Cancer genetics 2022 7 266-267 81-85. Vargason Ashlee B, Turner Clesson E, Shriver Craig D, Ellsworth Rachel |
The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers. Current opinion in urology 2022 7 32 (5): 445-450. Tiwari Raj, Clark Roderick, Fleshner Ne |
Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. Prostate cancer and prostatic diseases 2022 3 25 (3): 422-430. Xu Jianfeng, Resurreccion W Kyle, Shi Zhuqing, Wei Jun, Wang Chi-Hsiung, Zheng S Lilly, Hulick Peter J, Ross Ashley E, Pavlovich Christian P, Helfand Brian T, Isaacs William |
A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family. Current medical science 2022 3 42 (3): 666-672. Hu Peng-Zhi, Chen Xiang-Yu, Xiong Wei, Yang Zhi-Jian, Li Xiao-Rong, Deng Wen-Zhi, Gong Li-Na, Deng Hao, Yuan La-M |
Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study. JCO precision oncology 2022 1 5 1588-1602. Levine Monica D, Pearlman Rachel, Hampel Heather, Cosgrove Casey, Cohn David, Chassen Alexis, Suarez Adrian, Barrington David A, McElroy Joseph P, Waggoner Steven, Nakayama John, Billingsley Caroline, Resnick Kim, Andrews Stephen, Singh Sareena, Jenison Eric, Clements Aine, Neff Robert, Goodfellow Paul J, |
Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India. Molecular biology reports 2022 1 49 (4): 3025-3032. Rajagopal Taruna, Seshachalam Arun, Jothi Arunachalam, Rathnam Krishna Kumar, Talluri Srikanth, Venkatabalasubranian Sivaramakrishnan, Dunna Nageswara R |
Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. Scientific reports 2023 5 13 (1): 8536. Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Anne-Vibeke Lænkholm, Åke Borg, Anders Kvist, Therese Törngren, Uffe Birk Jensen, Susanne Eriksen Boonen, Mads Thomassen, Thorkild Terkels |
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation? Breast cancer (Dove Medical Press) 2023 2 15 163-173. Emiroglu Selman, Özkurt Enver, Cab?oglu Neslihan, Igci Abdullah, Saip Pinar, Yazici Hulya, Ozmen Tolga, Ozmen Vahit, Muslumanoglu Mahmut, Tukenmez Musta |
The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
ER-positive and BRCA2-mutated breast cancer: a literature review. European journal of medical research 2024 1 29 (1): 30. Pu-Chun Li, Yi-Fan Zhu, Wen-Ming Cao, Bei |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: